Koyfin Home > Directory > Health Care > Aeglea Biothera > Cost of Goods Sold

Aeglea Biothera Cost of Goods Sold Chart (AGLE)

Aeglea Biothera annual/quarterly Cost of Goods Sold from 2014 to 2020.
  • Aeglea Biothera Cost of Goods Sold for the quarter ending June 06, 2020 was $17m a -5.75% decrease of -1m year over year
  • Aeglea Biothera Cost of Goods Sold for the last 12 months ending June 06, 2020 was $67m a 11.98% increase of 8m year over year
  • Aeglea Biothera Annual Cost of Goods Sold for 2019 was $65m a 43.16% increase of 28m from 2018
  • Aeglea Biothera Annual Cost of Goods Sold for 2018 was $37m a 37.87% increase of 14m from 2017
  • Aeglea Biothera Annual Cost of Goods Sold for 2017 was $23m a 20.48% increase of 5m from 2016
Other Income Statement Metrics:
  • Aeglea Biothera EBITDA for the quarter ending December 12, 2018 was $-15m a 46.33% decrease of -7m year over year
  • Aeglea Biothera Net Income for the quarter ending December 12, 2018 was $-15m a 45.50% decrease of -7m year over year
  • Aeglea Biothera Total Revenue for the quarter ending June 06, 2018 was $2m a 46.97% increase of 1m year over year
View Chart On Koyfin

Quarterly AGLE Cost of Goods Sold Data

06/2020$17m
03/2020$15m
12/2019$18m
09/2019$18m
06/2019$15m
03/2019$14m
12/2018$12m
09/2018$9m
06/2018$9m
03/2018$7m

Annual AGLE Cost of Goods Sold Data

2019$65m
2018$37m
2017$23m
2016$18m
2015$11m
2014$7m